Therefore, it is important to screen for high risk patients with chronic inflammation or increased oxidative stress like metabolic syndrome, diabetes, chronic heart failure, or chronic atherosclerosis, before they should receive G-CSF treatment for acute coronary heart disease. The gene discussed is CSF3; the disease is metabolic syndrome.